Evaluation of central nervous system effects of Citrus limon essential oil in mice

Revista Brasileira de Farmacognosia

Volumn 21, Issue 4, 2011, Pages 668-673

  Campêlo, Lidianne Mayra Lopes ^a   de Lima, Sidney Gonçalo ^a   Feitosa, Chistiane Mendes ^a   de Freitas, R M D ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Anticonvulsant; Citrus limon; Essential oil; Mice

Indexed keywords

BETA CITRAL; CITRAL; CITRONELLAL; CITRUS LIMON EXTRACT; DIAZEPAM; ESSENTIAL OIL; FLUMAZENIL; GERANYL ACETATE; HERBACEOUS AGENT; LIMONENE; LIMONENE OXIDE; LINALOOL; NEROL; PENTETRAZOLE; PICROTOXIN; PLANT EXTRACT; TERPENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG MEGADOSE; EVALUATION; LATENT PERIOD; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PLANT LEAF;

EID: 80051953152     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2011005000086     Document Type: Article

References (38)

1. Adams RP 2007. Identification of essencial oil components by gas chromatography/massa spectroscopy. Allured: Baylor University.
2. Alencar JW, Craveiro AA, Matos FJA 1984. Kovats' indices as a preselection routine in mass spectra library search of volatiles. J Nat Prod 47: 890-892.
3. Alencar JW, Craveiro AA, Matos FJA, Machado MIL 1990. Kovats indices simulation in essential oils analysis. Quim. Nova 13: 282-284.
4. Almeida RN, Falcão ACGM, Diniz RST, Quintans-Júnior LJ, Polari RM, Barbosa-Filho JM, Agra MF, Duarte JC, Ferreira CD, Antoniolli AR, Araújo CC 1999. Metodologia para avaliação de plantas com atividade no sistema nervoso central e alguns dados experimentais. Rev Bras Farm 80: 72-76.
5. Asakura W, Matsumoto K, Ohta H, Watanbe H 1993. Effects of alpha 2-adrenergic drugs on REM sleep deprivationinduced increase in swimming activity. Pharmacol Biochem Behav 46: 111-115.
6. Benavente-Garcia O, Castillo J, Marin JR, Ortuno A, Del Rio JA 1997. Uses and properties of Citrus fl{ligature}avonoids. J Agricul Food Chem 45: 4505-4515.
7. Brooker DJR, Snape M, Johnson E, Ward D, Payne M 1997. Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia Brit J Clin Psychol 36: 287-296.
8. Carlini EA 2003. Plants and the central nervous system. Pharmacol Biochem Behav 75: 501-512.
9. Dallmeier K, Carlini EA 1981. Anesthetic, hypotermic, myorelaxant and anticonvulsant effects of synthetic eugenol derivatives and natural analogues. Pharmacology 22: 113-127.
10. De Sarro A, Cecchetti V, Fravolini V, Naccari F, Tabarrini O, De Sarro G 1999. Effects of novel 6-desfl{ligature}uoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice. Antimicrob Agents Chemother 43: 1729-1736.
11. Elangovan V, Sekar N, Govindasamy S 1994. Chemoprotective potential of dietary biofl{ligature}avonoids aginst 20-methylchloranthrene- induced tumorogenesis. Cancer Lett 87:107-113.
12. File SE, Pellow S 1986. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology 88: 1-11.
13. Freire CMM, Marques MOM, Costa, M 2006. Effects of seasonal variation on the central nervous system activity of Ocimum gratissimum L. essential oil. J Ethnopharmacol 105: 161-166.
14. Leite MP, Fassin Jr J, Baziloni EMF, Almeida RN, Mattei R, Leite JR 2008. Behavioral effects of essential oil of Citrus aurantium L. inhalation in rats. Rev Bras Farmacogn 18: 661-666.
15. Lehmann J, Hutchison A, McPherson SE, Mondadori C, Schmutz M, Sinton CM, Tsai C, Murphy DE, Steel DJ, Williams M, Cheney DL, Wood PL 1988. CGS 19755 a selective and competitive N-metil-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther 246: 65-75.
16. Löscher W, Schmidt D 2006. New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 69:183-272.
17. Matos FJA, Machado MIL, Craveiro AA, Barbosa-Filho JM 1999. Essential oil of Mentha x villosa Huds. J Essent Oil Res 11: 41-44.
18. Miyake Y, Yamamoto K, Morimitsu Y, Osawa T 1997. Isolation of C-glucosylfl{ligature}avone from lemon peel and antioxidative activity of fl{ligature}avonoid compounds in lemon fruit. J Agricul Food Chem 45: 4619-4623.
19. Miyake Y, Yamamoto K, Morimitsu Y, Osawa T 1998. Characterization of antioxidative fl{ligature}avonoids glycosides in lemon fruit. F Sci Tech Int Tokyo 4: 48-53.
20. Monforte MT, Trovato A, Kirjarainen S, Forestieri AM, Galati EM, Lo Curto RB 1995. Biological effects of hesperidin a Citrus fl{ligature}avonoid. (Note II): Hypolipidemic activity on experimental hypercholesterolemia in rat. Farmaco 9: 595-599.
21. Morais LCSL, Quintans-Júnior LJ, Franco CIF, Almeida JRGS, Almeida RN 2004. Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology. Pharmacol Biochem Behav 79: 745-749.
22. Netto SM, Warela RWB, Fechine MF, Queiroga MN, Quintans- Júnior LJ 2009. Anxiolytic-like effect of Rauvolfia ligustrina Willd. Ex Roem. & Schult. Apocynaceae, in the elevated plus-maze and hole-board tests. Rev Bras Farmacogn 19: 888-892.
23. Nicoll RA 2001. Introduction to the pharmacology of the central nervous system (CNS). In: Katzung BG (ed.) Basic and Clinical Pharmacology. 8. ed. New York: McGraw-Hill, p. 351-363.
24. Ngo Bum E, Schmutz M, Meyer C, Rakotonirina A, Bopelet M, Portet C, Jeker A, Rakotonirina SV, Olpe HR, Herrling P 2001. Anticonvulsant properties of the methanolic extract of Cyperus articulatus (Cyperaceae). J Ethnopharmacol 76: 145-150.
25. Nguyen QA, Paton C 2008. The use of aromatherapy to treat behavioral problems in dementia. Int J Geriatr Psychiatry 23: 337-346.
26. Olayiwola G, Obafemi CA, Taiwo FO 2007. Synthesis and neuropharmacological activity of some quinoxalinone derivatides. Afr J Biotechnol 6: 777-786.
27. Oliveira FA, Almeida RN, Sousa MFV, Barbosa-Filho JM, Diniz SA, Medeiros IA 2001. Anticonvulsant properties of N-salicyloyltryptamine in mice. Pharmacol Biochem Behav 68: 199-202.
28. Passos CS, Arbo MD, Rates SMK, Von Poser GL 2009. Terpenóides com atividade sobre o Sistema Nervoso Central (SNC). Rev Bras Farmacogn 19: 140-149.
29. Perez GRM, Perez LJA, Garcia DLM, Sossa MH 1998. Neuropharmacological activity of Solanum nigrum fruit. J Ethnopharmacol. 62: 43-48.
30. Pedersen ME, Vestergaard HT, Hansen SL, Bah S, Diallo D, Jäger AK 2009. Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions. J Ethnopharmacol 121: 472-475.
31. Quintans-Júnior LJ, Souza TT, Leite BS, Lessa NMN, Bonjardim LR, Santos MRV, Alves PB, Blank AF, Antoniolli AR 2008. Phythochemical screening and anticonvulsant activity of Cymbopogon winterianus Jowitt (Poaceae) leaf essential oil in rodents. Phytomedicine 15: 619-624.
32. Rang HP, Dale MM, Ritter JM, Moore PK 2003. Pharmacology, 5 ed. Edinburgh: Churchill Livingstone, p 585-587.
33. Rice-Evans CA, Miller NJ, Paganda G 1997. Antioxidant properties of phenolic compounds. Trends Plant. Sci. 2: 152-159.
34. Smith M, Wilcox KS, White HS 2007. Discovery of antiepileptic drugs. Neurotherapeutics 4: 12-17.
35. Stenhagen E, Abrahamson S, McLafferty FW 1974. Registry of mass spectra data base. Washington DC: Government Printing Office.
36. Tanaka T, Makita H, Mori H 1996. Chemoprotection of 4-NOOinduced oral carcinogenesis by dietary fl{ligature}avonoids diosmin and hesperidin. Rect Adv Gastroenter Carcinog 1: 1167-1170.
37. Westmoreland BF, Benarroch EE, Dube JR, Regan TJ, Sandok BA 1994. Medical Neurosciences. Rochester: Mayo Foundation, p 307-312.
38. Wolfe N, Herzberg J 1996. The study protocol of a blinded randomized-controlled cross-over trial of lavender oil as a treatment of behavioural symptoms in dementia. Int J Geriatr Psychiatry 11: 926-927.